5-Bromo-4-chloroindolyl 1,3-diacetate
CAS: 3030-06-6
Ref. 3D-FB00192
2g | 168,00 € | ||
5g | 271,00 € | ||
10g | 396,00 € | ||
25g | 678,00 € | ||
50g | 1.013,00 € |
Información del producto
- 1-Acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate5-Bromo-4-chloroindoxyl 1,3-diacetate
5-Bromo-4-chloroindolyl 1,3-diacetate (5BCDA) is a clinical response predictor of postoperative radiotherapy. It is an acr20 response predictor for the diagnosis of chronic hepatitis C and the disease activity index in women with genital herpes. 5BCDA has been found to be effective in reducing levels of IL-17a and IL-17f, which are cytokines that are important for immune responses. 5BCDA has also been shown to be effective in treating infectious diseases such as malaria and tuberculosis.
Propiedades químicas
Consulta técnica sobre: 3D-FB00192 5-Bromo-4-chloroindolyl 1,3-diacetate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.